Abstract:Abstract Background Glioblastoma is the most common primary malignant brain tumor. Because of the limited understanding of its pathogenesis, the prognosis of glioblastoma remains poor. This study was conducted to explore potential competing endogenous RNA (ceRNA) network chains and biomarkers in glioblastoma by performing integrated bioinformatics analysis. Methods Transcriptome expression data from The Cancer Genome Atlas database and Gene Expression Omnibus were analyzed to identify differentially expressed genes between glioblastoma and normal tissues. Biological pathways potentially associated with the differentially expressed genes were explored by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis, and a protein-protein interaction network was established using the STRING database and Cytoscape. Survival analysis using Gene Expression Profiling Interactive Analysis was based on the Kaplan–Meier curve method. A ceRNA network chain was established using the intersection method to align data from four databases (miRTarBase, miRcode, TargetScan, and lncBace2.0), and expression differences and correlations were verified by quantitative reverse-transcription polymerase chain reaction analysis and by determining the Pearson correlation coefficient. Additionally, an MTS assay and the wound-healing and transwell assays were performed to evaluate the effects of complement C1s (C1S) on the viability and migration and invasion abilities of glioblastoma cells, respectively. Results We detected 2842 differentially expressed (DE) mRNAs, 2577 DE long non-coding RNAs (lncRNAs), and 309 DE microRNAs (miRNAs) that were dysregulated in glioblastoma. The final ceRNA network consisted of six specific lncRNAs, four miRNAs, and four mRNAs. Among them, four DE mRNAs and one DE lncRNA were correlated with overall survival ( p < 0.05). C1S was significantly correlated with overall survival ( p = 0.015). In functional assays, knockdown of C1S inhibited the proliferation and invasion of glioblastoma cell lines. Conclusions We established four ceRNA networks that may influence the occurrence and development of glioblastoma. Among them, the MIR155HG/has-miR-129-5p/C1S axis is a potential marker and therapeutic target for glioblastoma. Knockdown of C1S inhibited the proliferation, migration, and invasion of glioblastoma cells. These findings clarify the role of the ceRNA regulatory network in glioblastoma and provide a foundation for further research.

Competing Endogenous RNA Networks in Glioma

Analyzing the Interactions of Mrnas, Mirnas, Lncrnas and Circrnas to Predict Competing Endogenous RNA Networks in Glioblastoma

Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma

Whole-transcriptome Sequencing with Cerna Regulation Network Construction and Verification in Glioblastoma

Sequencing and Bioinformatics analysis of lncRNA/circRNA-miRNA-mRNA in Glioblastoma multiforme

The Role of Non-Coding RNAs in Glioma

In silico characterization of competing endogenous RNA network in glioblastoma multiforme with a systems biology approach

Non-Coding RNAs in Glioma Microenvironment and Angiogenesis

Integrated Analysis of ceRNA Network to Reveal Potential Prognostic Biomarkers for Glioblastoma

Integrative Analysis of Mirna-Mediated Competing Endogenous RNA Network Reveals the Lncrnas-Mrnas Interaction in Glioblastoma Stem Cell Differentiation

Current Landscape of Tumor-Derived Exosomal Ncrnas in Glioma Progression, Detection, and Drug Resistance.

Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways

LncRNAs: New Players in Gliomas, with Special Emphasis on the Interaction of Lncrnas with EZH2.

Exploring Long Noncoding RNAs in Glioblastoma: Regulatory Mechanisms and Clinical Potentials

Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network

Regulation of a novel circATP8B4/miR-31-5p/nestin ceRNA crosstalk in proliferation, motility, invasion and radiosensitivity of human glioma cells

Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications

Competing Endogenous RNA in Cancer: a New Pattern of Gene Expression Regulation.

ceRNA network analysis reveals prognostic markers for glioblastoma

Competing Endogenous RNAs in Lung Cancer

ceRNA in cancer: possible functions and clinical implications